Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Jiangmen Hengjian Pharmaceutical
Jiangmen, Guangdong Sheng, China
- Ownership
- Private
- Development stage
- Other
01
Overview
Jiangmen Hengjian Pharmaceutical develops and manufactures pharmaceutical products, including small molecule drugs such as norfloxacin capsules. The company has conducted at least 14 clinical trials, including bioequivalence studies for generic drugs. It also appears as the originator of combination topical therapies for dermatitis that have reached approval through a subsidiary or partner[1][5].
- Therapeutic areas
- DermatologyInfectious Diseases
- Modalities
- Small molecule
- Industry
- Biotech
Beyond the preview
Go deeper on Jiangmen Hengjian Pharmaceutical.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Jiangmen Hengjian Pharmaceutical.